TRAVELXP
Travelxp, world’s leading travel channel, opens a window to the world for the viewers of Slovakia & Czech Republic through its fully localized launch on Slovak Telekom. Travelxp’s foray into Slovak is an important step as it further expands the reach and strengthens its foothold in the CEE region. This is the third language after Serbian & Croatian in which Travelxp is fully localized apart from the primary English feed.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171205005094/en/
With travel content filmed in over 40+ countries, Travelxp brings to its audience a never seen before experience of travelling from their homes. Bringing the world closer than ever, viewers would love the extraordinary images woven with in depth research.
Travelxp, offers 100% originally-produced premium travel and lifestyle programming, distributed to over 50 million homes globally, with a classic mix of path-breaking travel content in HD and 4K.
“After localizing Travelxp in Czech language, our endeavour is to gradually showcase more content originating from Slovakia and Czech Republic. Taking local content globally and getting global content locally is the core philosophy of Travelxp. We would be working with independent content producers in the region to have the local perspective as diversity of content is key to Travelxp’s offering,” commented Sumant Bahl, Director, Travelxp Europe.
“Telekom traditionally brings high-quallity family and sports content to its customers. Enhancing the portfolio with Travelxp is another boost to the quality and attractiveness of our TV services,” explained Andrej Miklanek, Marketing Expert, Slovak Telekom.
Jozef Pipek, Managing Director, IFC Media, representing Travelxp in Czech Republic & Slovakia states also commented, “We are very thankful and proud to launch a localised version of Travelxp in Czech Republic and Slovakia. It’s great to have a chance to cooperate with market leaders Slovak Telekom and T-Mobile Czech Republic and their great teams. Also, our next goal is to develop Travelxp 4K.”
About Travelxp
Travelxp is an initiative of Media Worldwide Limited, UK and Celebrities Management Private Limited, India, with interest in broadcast, advertising, media consulting and related services. The company operates 10 (ten) satellite channels across the globe across its group companies. Travelxp is the world’s leading travel channel and launched Travelxp 4K, the world’s first 4K HDR channel in North America & Europe in collaboration with SES and Eutelsat respectively.
Visit: www.travelxp.tv
About Slovak Telekom
Slovak Telekom is the largest Slovak multimedia operator and has many years of experience and a responsible approach towards doing business. Slovak Telekom provides products and services under the Telekom brand for individuals, households and corporate clients via fixed-line and mobile networks. Slovak Telekom introduces international knowledge, innovative solutions and the latest technological trends. Slovak Telekom is part of the multinational Deutsche Telekom Group. The Sole Shareholder of Slovak Telekom is Deutsche Telekom, Europe B.V., holding 100% of shares.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171205005094/en/
Contact:
Travelxp
Trishala Maheshwari
Tel: +91 9820133783
trishala.maheshwari@travelxp.tv
or
Slovak
Telekom
Peter Galik
Tel.: +421 225 8820426
presscentrum@telekom.sk
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom